Oragenics Inc (OGEN) income statement
OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.19−0.02 (-10.00%)
Close on Nov 18, 2026Market cap $852.76KP/E –Yield –
Oragenics Inc financial ratios
See a number that looks wrong?
Close on Nov 18, 2026Market cap $852.76KP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Margins | |||||||||||||||||
| Gross margin | – | – | – | – | – | – | – | – | – | – | – | 60.7% | 66.7% | 34.0% | 50.6% | 30.3% | – |
| Operating margin | – | – | -55,519.9% | -10,964.6% | -18,130.3% | – | – | – | – | – | – | -618.8% | -1,570.4% | -933.5% | -508.6% | -603.8% | – |
| EBITDA margin | – | – | -55,447.1% | -10,930.7% | -18,082.9% | – | – | – | – | – | – | -615.9% | -1,563.0% | -927.9% | -503.1% | -600.5% | – |
| Pre-tax margin | – | – | -54,858.1% | -10,864.0% | -18,062.0% | – | – | – | – | – | – | -616.0% | -1,556.7% | -982.9% | -531.6% | -652.3% | – |
| Net profit margin | – | – | -54,858.1% | -10,864.0% | -18,062.0% | – | – | – | – | – | – | -616.0% | -1,556.7% | -982.9% | -531.6% | -596.3% | – |
| Free cash flow margin | – | – | – | -11,675.7% | -15,535.8% | – | – | – | – | – | – | -603.2% | -657.2% | -392.2% | – | -499.4% | – |
| Returns on capital | |||||||||||||||||
| Return on equity | -243.9% | -1,550.1% | -318.0% | -81.1% | -93.8% | -259.3% | -122.1% | -153.2% | -452.9% | -182.2% | -155.5% | -44.2% | -128.2% | -2,487.9% | 152.4% | -2,108.6% | – |
| Return on assets | -170.6% | -328.3% | -209.4% | -66.5% | -67.0% | -137.5% | -74.5% | -67.8% | -116.8% | -139.0% | -138.5% | -41.4% | -117.6% | -222.7% | -512.8% | -451.8% | – |
| Return on tangible assets | -170.6% | -328.3% | -209.4% | -66.5% | -67.0% | -137.5% | -74.5% | -67.8% | -116.8% | -139.0% | -138.5% | -41.4% | -117.6% | -222.7% | -512.8% | -451.8% | – |
| Return on capital employed | – | – | -256.0% | -72.2% | -71.5% | -151.2% | -81.9% | -73.5% | -144.8% | -222.0% | -156.4% | -44.4% | -129.3% | -2,362.8% | 181.9% | -7,849.0% | – |
| NOPAT | -$7.40M | -$8.34M | -$16.51M | -$11.39M | -$12.46M | -$21.05M | -$12.54M | -$7.90M | -$5.31M | -$6.75M | -$9.31M | -$4.60M | -$12.81M | -$9.82M | -$5.80M | -$6.24M | – |
| Cash flow quality | |||||||||||||||||
| OCF / Sales | – | – | -19,363.3% | -11,578.7% | -15,485.3% | – | – | – | – | – | – | -591.4% | -655.3% | -391.3% | -380.4% | -492.7% | – |
| OCF / Net income | 0.94 | 0.81 | 0.35 | 1.07 | 0.86 | 0.64 | 0.84 | 0.92 | 0.95 | 1.01 | 0.44 | 0.96 | 0.42 | 0.40 | 0.72 | 0.83 | – |
| FCF / OCF | – | – | – | 100.8% | 100.3% | – | 100.2% | 101.4% | – | 100.4% | 102.0% | 102.0% | 100.3% | 100.2% | – | 101.4% | – |
| FCF / Net income | – | – | – | 1.07 | 0.86 | – | 0.84 | 0.93 | – | 1.01 | 0.45 | 0.98 | 0.42 | 0.40 | – | 0.84 | – |
| FCF / EBITDA | – | – | – | 106.8% | 85.9% | – | 82.4% | 92.4% | – | 83.9% | 45.2% | 97.9% | 42.0% | 42.3% | – | 83.2% | – |
| Unlevered free cash flow | – | – | – | -$15.34M | -$13.50M | – | -$13.03M | -$9.20M | – | -$7.10M | -$5.23M | -$5.67M | -$6.77M | -$4.71M | – | -$6.51M | – |
| Levered free cash flow | – | – | – | -$15.36M | -$13.51M | – | -$13.04M | -$9.20M | – | -$7.10M | -$5.29M | -$5.67M | -$6.78M | -$5.22M | – | -$6.54M | – |
| Efficiency | |||||||||||||||||
| Asset turnover | – | – | 0.00 | 0.01 | 0.00 | – | – | – | 0.00 | 0.00 | 0.00 | 0.07 | 0.08 | 0.23 | 0.96 | 0.76 | – |
| Fixed asset turnover | – | – | 0.62 | 1.58 | 1.97 | – | – | – | 0.00 | 0.00 | 0.00 | 13.80 | 18.51 | 11.42 | 7.67 | 5.74 | – |
| Receivables turnover | – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 23.49 | 15.38 | 16.40 | 13.40 | 10.64 | – |
| Days sales outstanding | – | – | – | – | – | – | – | – | – | – | – | 15.5 | 23.7 | 22.3 | 27.2 | 34.3 | – |
| Payables turnover | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.46 | 0.33 | 0.61 | 0.44 | 0.60 | – |
| Days payables outstanding | – | – | – | – | – | – | – | – | – | – | – | 800.0 | 1,098.9 | 602.0 | 832.4 | 606.4 | – |
| Inventory turnover | – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 1.02 | 1.66 | 2.93 | 1.92 | 3.42 | – |
| Days inventory outstanding | – | – | – | – | – | – | – | – | – | – | – | 359.3 | 219.3 | 124.6 | 189.8 | 106.7 | – |
| Operating cycle | – | – | – | – | – | – | – | – | – | – | – | 374.8 | 243.0 | 146.9 | 217.1 | 141.0 | – |
| Cash conversion cycle | – | – | – | – | – | – | – | – | – | – | – | -425.2 | -855.9 | -455.1 | -615.4 | -465.4 | – |
| CapEx to revenue | – | – | – | 97.0% | 50.4% | – | – | – | – | – | – | 11.8% | 1.8% | 0.83% | – | 6.7% | – |
| CapEx to OCF | – | – | – | -0.84% | -0.33% | – | -0.19% | -1.4% | – | -0.38% | -2.0% | -2.0% | -0.28% | -0.21% | – | -1.4% | – |
| CapEx to depreciation | – | – | – | 2.85 | 1.06 | – | 0.40 | 4.14 | – | 0.36 | 1.44 | 4.00 | 0.25 | 0.15 | – | 2.06 | – |
| Liquidity | |||||||||||||||||
| Current ratio | – | – | 2.15 | 8.95 | 19.17 | 13.40 | 10.18 | 18.79 | 8.01 | 3.14 | 5.38 | 13.84 | 16.93 | 8.28 | 0.12 | 0.92 | – |
| Quick ratio | – | – | 2.15 | 8.95 | 19.17 | 13.40 | 10.18 | 18.79 | 8.01 | 3.14 | 5.08 | 13.29 | 16.64 | 8.18 | 0.07 | 0.76 | – |
| Cash ratio | – | – | 1.94 | 7.16 | 18.87 | 13.14 | 9.87 | 17.31 | 6.86 | 3.04 | 4.85 | 13.12 | 16.39 | 7.90 | 0.02 | 0.08 | – |
| Working capital | – | – | $2.07M | $12.69M | $26.26M | $16.64M | $16.99M | $20.77M | $6.29M | $2.88M | $4.59M | $10.23M | $15.81M | $9.15M | -$8.33M | -$127.52K | – |
| Net current asset value | $8.28M | -$211.89K | $2.07M | $12.54M | $25.96M | $16.15M | $16.32M | $20.77M | $6.29M | $2.88M | $4.59M | $10.23M | $15.81M | $9.15M | -$8.33M | -$2.13M | – |
| Leverage | |||||||||||||||||
| Assets to equity | 1.22 | -6.95 | 1.57 | 1.13 | 1.07 | 1.11 | 1.15 | 1.06 | 1.14 | 1.45 | 1.22 | 1.08 | 1.06 | 1.14 | -0.15 | -0.91 | – |
| Interest coverage | |||||||||||||||||
| EBIT / Interest expense | -11.91 | -353.99 | -683.37 | -954.83 | -1,000.95 | -2,493.35 | -2,175.01 | -1,727.30 | -31.06 | -2,075.44 | -153.66 | -1,443.30 | -924.29 | -18.96 | -22.10 | -233.40 | – |
| EBITDA / Interest expense | – | – | -682.47 | -951.87 | -998.34 | -2,488.51 | -2,166.43 | -1,722.09 | -30.75 | -2,057.21 | -152.73 | -1,436.43 | -919.93 | -18.85 | -21.87 | -232.14 | – |
| (EBITDA − CapEx) / Interest expense | – | – | – | -960.31 | -1,001.12 | – | -2,169.89 | -1,743.65 | – | -2,063.81 | -154.07 | -1,463.90 | -921.00 | -18.87 | – | -234.74 | – |
| Per share | |||||||||||||||||
| Revenue per share | – | – | 0.01 | 0.0011 | 0.04 | – | – | – | 0.00 | 0.00 | 0.00 | 15.07 | 16.63 | 28.21 | 142.14 | 134.05 | – |
| EPS (basic) | -4.56 | -47.88 | -9.18 | -7.11 | -8.09 | -27.26 | -21.46 | -50.46 | -79.46 | -91.06 | -185.60 | -92.80 | -324.80 | -429.20 | -777.20 | -823.60 | – |
| EPS (diluted) | -4.56 | -47.88 | -9.18 | -7.11 | -8.12 | -27.26 | -21.46 | -50.46 | -79.46 | -91.06 | -185.60 | -92.80 | -324.80 | -429.20 | -777.20 | -823.60 | – |
| Book value per share | 1.94 | -0.51 | 0.51 | 0.10 | 11.90 | 6.11 | 13.48 | 29.13 | 0.08 | 35.02 | 68.84 | 165.70 | 255.22 | 195.54 | -804.89 | -194.52 | – |
| Tangible book value per share | 1.94 | -0.51 | 0.51 | 0.10 | 11.90 | 6.11 | 13.48 | 29.13 | 0.08 | 35.02 | 68.84 | 165.70 | 255.22 | 195.54 | -804.89 | -194.52 | – |
| Cash per share | 1.97 | 2.06 | 1.13 | 0.10 | 13.61 | 11.15 | 22.97 | 39.82 | 72.57 | 48.18 | 73.97 | 167.51 | 262.27 | 210.24 | 16.90 | 13.53 | – |
| Operating cash flow per share | -2.16 | -20.52 | -2.37 | -0.13 | -6.73 | -10.71 | -16.36 | -17.89 | -74.89 | -83.54 | -75.51 | -89.12 | -109.00 | -110.39 | -540.72 | -660.43 | – |
| Free cash flow per share | – | – | – | -0.13 | -6.75 | – | -16.39 | -18.14 | – | -83.86 | -77.01 | -90.90 | -109.30 | -110.63 | – | -669.45 | – |
| CapEx per share | – | – | – | 0.0011 | 0.02 | – | 0.03 | 0.25 | – | 0.32 | 1.49 | 1.77 | 0.30 | 0.24 | – | 9.02 | – |
| Valuation at period end | |||||||||||||||||
| Market cap | $3.23M | $104.01M | $433.73M | $400.45M | $1.61B | $849.99M | $748.58M | $490.86M | $359.18M | $823.01M | $1.70B | $999.28M | $2.63B | $2.23B | $178.13M | – | – |
| Enterprise value | -$8.17M | $100.87M | $427.96M | $386.50M | $1.58B | $839.94M | $726.29M | $477.05M | $356.25M | $817.89M | $1.69B | $987.51M | $2.62B | $2.22B | $178.13M | – | – |
| P/S | – | – | 11,519x | 3,045x | – | – | – | – | – | – | – | 1,063x | 2,549x | 1,674x | 123x | – | – |
| P/B | 0.4x | -491x | 275x | 35.1x | 67.6x | 87.9x | 69.8x | 33.2x | 53,600x | 278x | 359x | 96.7x | 166x | 241x | -21.8x | – | – |
| P/TBV | 0.4x | -491x | 275x | 35.1x | 67.6x | 87.9x | 69.8x | 33.2x | 53,600x | 278x | 359x | 96.7x | 166x | 241x | -21.8x | – | – |
| P/Gross profit | – | – | – | – | – | – | – | – | – | – | – | 1,752x | 3,819x | 4,917x | 244x | – | – |
| P/OCF | -0.3x | -12.1x | -59.5x | -26.3x | -120x | -50.1x | -57.5x | -54.1x | -56.4x | -116x | -327x | -180x | -389x | -428x | -32.4x | – | – |
| EV/Sales | – | – | 11,366x | 2,939x | – | – | – | – | – | – | – | 1,051x | 2,541x | 1,665x | 123x | – | – |
| EV/Gross profit | – | – | – | – | – | – | – | – | – | – | – | 1,731x | 3,807x | 4,891x | 244x | – | – |
| EV/EBIT | 0.9x | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| EV/OCF | 0.9x | -11.7x | -58.7x | -25.4x | -117x | -49.5x | -55.8x | -52.5x | -56.0x | -116x | -326x | -178x | -388x | -425x | -32.4x | – | – |
| Earnings yield | -304.5% | -10.2% | -4.8% | -3.6% | -0.98% | -3.1% | -2.1% | -2.0% | -1.9% | -0.85% | -0.69% | -0.58% | -0.61% | -0.59% | -4.3% | – | – |
| FCF yield | – | – | – | -3.8% | -0.84% | – | -1.7% | -1.9% | – | -0.86% | -0.31% | -0.57% | -0.26% | -0.23% | – | – | – |
| Shareholder yield | |||||||||||||||||
| Buyback yield | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.00% | – | – |
| Shareholder yield | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.00% | – | – |
| Cost structure | |||||||||||||||||
| R&D to revenue | – | – | 41,140.4% | 7,658.6% | 12,169.8% | – | – | – | – | – | – | 326.1% | 906.7% | 590.3% | 169.6% | 153.9% | – |
| SG&A to revenue | – | – | – | – | – | – | – | – | – | – | – | 353.4% | 730.5% | 377.3% | 389.6% | 480.2% | – |
| Stock-based comp to revenue | – | – | 2,700.5% | 564.3% | 1,940.5% | – | – | – | – | – | – | 19.6% | 334.2% | 96.2% | 87.4% | 51.0% | – |
| Per employee | |||||||||||||||||
| Total employees | 3 | 3 | 5 | 6 | 5 | 7 | 7 | 6 | 6 | 14 | 15 | 12 | 9 | 10 | 3 | 3 | 3 |
| Revenue per employee | – | – | $7.53K | $21.92K | – | – | – | – | $0 | $0 | $0 | $78.33K | $114.69K | $133.18K | $481.48K | $436.30K | – |
| Gross profit per employee | – | – | – | – | – | – | – | – | $0 | $0 | $0 | $47.53K | $76.54K | $45.33K | $243.61K | $132.37K | – |
| Operating profit per employee | -$3.12M | -$3.52M | -$4.18M | -$2.40M | -$3.15M | -$3.81M | -$2.27M | -$1.67M | -$1.12M | -$610.18K | -$785.39K | -$484.71K | -$1.80M | -$1.24M | -$2.45M | -$2.63M | – |
| Net income per employee | -$3.28M | -$3.52M | -$4.13M | -$2.38M | -$3.14M | -$3.78M | -$2.22M | -$1.65M | -$1.12M | -$500.95K | -$780.76K | -$482.46K | -$1.79M | -$1.31M | -$2.56M | -$2.60M | – |
| Free cash flow per employee | – | – | – | -$2.56M | -$2.70M | – | -$1.86M | -$1.53M | – | -$507.30K | -$352.80K | -$472.48K | -$753.70K | -$522.30K | – | -$2.18M | – |
| Growth | |||||||||||||||||
| Revenue 1Y growth | – | – | -71.4% | 51.2% | – | – | – | – | – | – | -100.0% | -8.9% | -22.5% | -7.8% | 10.4% | – | – |
| Revenue 3Y CAGR | – | – | – | – | – | – | – | – | – | – | – | -13.3% | -7.6% | – | – | – | – |
| Revenue 10Y CAGR | – | – | -28.2% | -20.7% | -24.5% | – | – | – | – | – | – | – | – | – | – | – | – |
| Gross profit 1Y growth | – | – | – | – | – | – | – | – | – | – | -100.0% | -17.2% | 52.0% | -38.0% | 84.0% | – | – |
| Gross profit 3Y CAGR | – | – | – | – | – | – | – | – | – | – | – | -7.9% | 20.2% | – | – | – | – |
| EBIT 1Y growth | 11.3% | 49.5% | -45.0% | 8.6% | 40.8% | -67.8% | -58.9% | -48.8% | 21.4% | 27.5% | -102.5% | 64.1% | -30.4% | -69.2% | 7.0% | – | – |
| EBITDA 1Y growth | – | – | -45.2% | 8.6% | 40.8% | -68.1% | -58.7% | -49.8% | 21.4% | 27.7% | -102.3% | 64.1% | -30.6% | -70.0% | 7.5% | – | – |
| Net income 1Y growth | 6.9% | 48.8% | -44.6% | 9.1% | 40.6% | -69.8% | -57.0% | -47.3% | 4.0% | 40.1% | -102.3% | 64.0% | -22.8% | -70.5% | 1.6% | – | – |
| Diluted EPS 1Y growth | 90.5% | -421.6% | -29.1% | 12.4% | 70.2% | -27.0% | 57.5% | 36.5% | 12.7% | 50.9% | -100.0% | 71.4% | 24.3% | 44.8% | 5.6% | – | – |
| Operating cash flow 1Y growth | -7.5% | -17.9% | 52.1% | -13.1% | 20.5% | -30.3% | -43.3% | -42.7% | 10.1% | -36.3% | 6.6% | 17.8% | -29.8% | 5.1% | 14.8% | – | – |
| Free cash flow 1Y growth | – | – | – | -13.6% | – | – | -41.6% | – | – | -34.2% | 6.7% | 16.4% | -29.9% | – | – | – | – |
| CapEx 1Y growth | – | – | – | 190.6% | – | – | -79.8% | – | – | -73.5% | -7.4% | 488.4% | 69.5% | – | – | – | – |
| CapEx 3Y CAGR | – | – | – | 71.7% | -29.4% | – | -2.5% | 6.8% | – | 13.1% | 109.8% | – | -40.2% | – | – | – | – |
| CapEx 5Y CAGR | – | – | – | – | 10.1% | – | -25.6% | 46.0% | – | – | 3.1% | – | – | – | – | – | – |
| CapEx 10Y CAGR | – | – | – | 27.7% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Total assets 1Y growth | 583.7% | -70.4% | -66.3% | -47.7% | 51.1% | -5.4% | -10.4% | 205.6% | 67.4% | -25.4% | -48.1% | -33.9% | 60.5% | 727.8% | -26.7% | – | – |
| Total assets 3Y CAGR | -12.0% | -62.6% | -35.7% | -9.3% | 8.6% | 37.3% | 66.1% | 56.3% | -13.5% | -36.5% | -18.0% | 106.4% | 113.6% | – | – | – | – |
| Total assets 5Y CAGR | -11.6% | -40.5% | -25.8% | 15.4% | 45.6% | 26.4% | 12.2% | 5.5% | -7.2% | 27.7% | 27.3% | – | – | – | – | – | – |
| Total assets 10Y CAGR | 5.7% | -18.3% | -11.5% | 3.5% | 36.4% | 26.9% | – | – | – | – | – | – | – | – | – | – | – |
| Total equity 1Y growth | 4,008.4% | -106.7% | -75.6% | -50.9% | 57.2% | -2.2% | -17.5% | 230.6% | 113.0% | -37.3% | -54.2% | -34.7% | 71.6% | 212.9% | -330.6% | -172.0% | – |
| Total equity 3Y CAGR | -14.0% | – | -42.7% | -8.9% | 8.2% | 38.7% | 79.8% | 64.0% | -15.1% | -42.8% | -20.0% | – | – | 51.8% | – | – | – |
| Total equity 5Y CAGR | -13.2% | – | -31.4% | 15.5% | 54.9% | 28.9% | 10.8% | 5.7% | -7.3% | – | – | 31.4% | – | – | – | – | – |
| Total equity 10Y CAGR | 5.8% | – | -14.9% | 3.5% | – | – | 20.6% | – | – | – | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.